Skip to main content
. Author manuscript; available in PMC: 2021 Aug 26.
Published in final edited form as: J Transl Sci. 2020 Sep 16;7(3):10.15761/jts.1000421. doi: 10.15761/jts.1000421

Table 3.

Linear regression model of MTD, PVT and Aggressiveness Index score as categorical. All models on HDL and LDL categories combined.

MTD (cm) PVT (No/Yes) Aggressiveness Index score (4/≥5)
Parameter β se(β) p-value 95% C.I. OR se(OR) p-value 95% C.I. OR se(OR) p-value 95% C.I.
HDL* & LDL¥
High Low (Ref. category) 1 1 1
High High 1.25 1.24 0.31 −1.19 to 3.70 1.14 0.79 0.85 0.29 to 4.45 1.08 0.78 0.92 0.26 to 4.43
Low Low 1.25 0.33 <0.001 0.60 to 1.91 1.25 0.25 0.26 0.85 to 1.84 1.11 0.21 0.56 0.77 to 1.61
Low High 3.20 0.77 <0.001 1.68 to 4.72 3.04 1.29 0.009 1.32 to 6.97 12.91 13.31 0.01 1.71 to 97.42
*

HDL (mg/dL): High (0), [≥50(F)]/[≥40(M)]; Low (1), [<50(F)]/[<40(M)];

¥

LDL (mg/dL): Low (0), <160; High (1), ≥160. Abbreviations: β, coefficient; se (β), standard error of coefficient; OR, Odds-Ratio; se (OR), standard error of Odds-Ratio; MTD, Maximum Tumor Diameter; PVT, Portal Vein Thrombosis; HDL, High Density Lipoprotein Cholesterol; LDL, Low Density Lipoprotein Cholesterol. Aggressiveness Index as sum of scores: MTD (in terciles): MTD<4.5; 4.5≤MTD≤9.6; MTD>9.6; scores 1, 2, 3 respectively; AFP (cut-off): AFP<100; 100≤AFP≤1000; AFP>1000 ng/ml; scores 1, 2, 3 respectively; PVT (No/Yes): PVT (No); PVT (Yes); scores 1, 3 respectively; Tumor Nodules (number): Nodules≤3; Nodules>3; scores 1, 3 respectively